Ezetimib-Rosuvastatin-Mepha 10 mg / 40 mg, Filmtabletten - 90 Swissmedic Key 68437008 Registration Holder Mepha Pharma AG Name Ezetimib-Rosuvastatin-Mepha 10 mg / 40 mg, Filmtabletten Date of registration 27.04.2022 Introduction of Sequence 11.07.2025 ATC-Classification Rosuvastatin and Ezetimibe (C10BA06) Revision date WHO WHO-DDD Valid until 26.04.2027 Index Therapeuticus (BSV) 07.12. Show package size 90 Index Therapeuticus (Swissmedic) 07.12. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680684370083 Medication Code Synthetika Pharmacode Disponibility
Composition ezetimibum 10 mg, rosuvastatinum 40.0 mg ut rosuvastatinum calcicum, lactosum monohydricum 200.5 mg, carmellosum natricum conexum, povidonum K 29-32, natrii laurilsulfas, cellulosum microcristallinum, hypromellosum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 5.04 mg, E 171, macrogolum 4000, pro compresso obducto corresp. natrium 3.02 mg. Packungsbestandteile Galenic Form Filmtabletten Active Agent Dose Ezetimibum 10 mg Rosuvastatinum 40 mg
Inactive agents Dose additional_information Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. Hypromellosum Überzug Lactosum Monohydricum 5.04 mg Macrogolum 4000 Magnesii Stearas Natrii Laurilsulfas Povidonum K 29-32 Pro Compresso Obducto Silica Colloidalis Anhydrica
Source Data was imported : 07.08.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
